Imatinib might constitute a treatment option for lung involvement in COVID-19-Reference-Cited by-同舟云学术

Imatinib might constitute a treatment option for lung involvement in COVID-19

Published:2020-07 Issue:7 Volume:19 Page:102565
ISSN:1568-9972
Container-title:Autoimmunity Reviews
language:en
Short-container-title:Autoimmunity Reviews

Author:

Bernal-Bello David,Jaenes-Barrios Beatriz,Morales-Ortega Alejandro,Ruiz-Giardin José Manuel,García-Bermúdez Virginia,Frutos-Pérez Begoña,Farfán-Sedano Ana Isabel,de Ancos-Aracil Cristina,Bermejo Fernando,García-Gil Mario,Zapatero-Gaviria Antonio,San Martín-López Juan Víctor

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference35 articles.

1. The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease;McGonagle;Autoimmun Rev,2020

2. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2);Yao;Clin Infect Dis,2020

3. A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus—a possible reference for coronavirus disease-19 treatment option;Yao;J Med Virol,2020

4. Baricitinib as potential treatment for 2019-nCoV acute respiratory disease;Richardson;Lancet,2020

5. COVID-19: consider cytokine storm syndromes and immunosuppression;Mehta;Lancet,2020

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Short- and long-term effects of imatinib in hospitalized COVID-19 patients: A randomized trial;Journal of Infection;2024-09

2. Predictions based on inflammatory cytokine profiling of Egyptian COVID-19 with 2 potential therapeutic effects of certain marine-derived compounds;International Immunopharmacology;2024-01

3. Impact of Imatinib on reducing the painful crisis in patients with sickle cell disease;Hematology, Transfusion and Cell Therapy;2023-08

4. Targeting Inflammation in Non-Small Cell Lung Cancer through Drug Repurposing;Pharmaceuticals;2023-03-16

5. Baricitinib or imatinib in hospitalized COVID‐19 patients: Results from COVINIB, an exploratory randomized clinical trial;Journal of Medical Virology;2023-01-19